Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations

Christian Breuer1, Jun Oh, Gerhard-J Molderings

  • 1Department of General Pediatrics, University Children's Hospital, Moorenstr. 5, 40225 Düsseldorf, Germany. christian.breuer@med.uni-duesseldorf.de

Insights

Interstitial cells of Cajal (ICCs) may cause slow-transit constipation (STC). This study links ICC morphological changes and c-kit alterations to congenital gastrointestinal motility disorders in a pediatric patient.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Motility Research
  • Developmental Biology

Background:

  • Constipation and fecal impaction are common in children, particularly those with neurological impairments.
  • Slow-transit constipation (STC) presents diagnostic and therapeutic challenges, with its etiology often unknown.
  • Interstitial cells of Cajal (ICCs), the gastrointestinal pacemakers, are increasingly implicated in STC pathophysiology.

Observation:

  • This study details the first reported case of a patient with histological ICC morphological alterations.
  • The patient exhibited multiple alterations in c-kit mRNA, which encodes the crucial receptor tyrosine kinase Kit (CD117).
  • The c-kit protein is essential for ICC development and function.

Findings:

  • Histological analysis revealed significant morphological abnormalities in the patient's ICCs.
  • Multiple alterations were identified at the c-kit mRNA level, suggesting a molecular basis for the ICC defects.
  • These molecular changes provide a potential explanation for the observed ICC dysfunction.

Implications:

  • The findings suggest that congenital alterations in ICC development, linked to c-kit gene expression, can cause pediatric gastrointestinal motility disorders.
  • This research offers a novel perspective on the etiology of STC, particularly in cases with congenital underpinnings.
  • Understanding the role of c-kit in ICC development may open new avenues for diagnosing and treating severe constipation in children.

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...